Given the rapid evolution of this field, future breakthroughs, including new drug approvals and expanded indications, necessitate systematic updates of the literature
The FDA has just approved a game-changing option for weight loss medication: the first oral GLP-1 drug approved specifically for obesity treatment
Haninger-Vacariu N et al
Wound Healing BPC 157 has demonstrated remarkable effectiveness in healing various types of wounds, including deep burns
Instead of large, infrequent doses, smaller amounts are administered more consistently to maintain stable levels in the body
Limitations, Side Effects and Unanswered Questions Some concerns around GLP-1s, notably insurance approval and out-of-pocket cost, will remain a consideration regardless of intended use